DekaBank Deutsche Girozentrale’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1B Hold
4,411,321
1.81% 7
2025
Q4
$709M Hold
4,411,321
1.23% 12
2025
Q3
$799M Hold
4,411,321
1.34% 8
2025
Q2
$675M Sell
4,411,321
-71,750
-2% -$11M 1.2% 10
2025
Q1
$731M Buy
4,483,071
+71,750
+2% +$11.2M 1.43% 9
2024
Q4
$637M Hold
4,411,321
1.18% 11
2024
Q3
$713M Buy
4,411,321
+52,543
+1% +$8.37M 1.32% 9
2024
Q2
$638M Sell
4,358,778
-124,293
-3% -$18.5M 1.15% 12
2024
Q1
$709M Buy
4,483,071
+86,655
+2% +$13.8M 1.32% 10
2023
Q4
$688M Buy
4,396,416
+200,193
+5% +$30.7M 1.41% 8
2023
Q3
$658M Buy
4,196,223
+247,124
+6% +$40.8M 1.52% 7
2023
Q2
$652M Buy
3,949,099
+85,219
+2% +$13.8M 1.46% 6
2023
Q1
$596M Buy
3,863,880
+84,939
+2% +$13.7M 1.5% 6
2022
Q4
$670M Sell
3,778,941
-426,637
-10% -$73.7M 1.77% 6
2022
Q3
$689M Buy
4,205,578
+415,884
+11% +$70.4M 2.03% 6
2022
Q2
$668M Sell
3,789,694
-142,803
-4% -$25.4M 1.94% 6
2022
Q1
$707M Buy
3,932,497
+322,927
+9% +$54.9M 1.72% 6
2021
Q4
$620M Buy
3,609,570
+216,703
+6% +$35.5M 1.51% 7
2021
Q3
$560M Buy
3,392,867
+332,424
+11% +$56.7M 1.56% 6
2021
Q2
$501M Buy
3,060,443
+216,286
+8% +$35.8M 1.46% 7
2021
Q1
$469M Buy
2,844,157
+576,158
+25% +$93.2M 1.56% 6
2020
Q4
$353M Buy
2,267,999
+308,206
+16% +$45.5M 1.32% 7
2020
Q3
$289M Buy
1,959,793
+323,964
+20% +$47.9M 1.28% 10
2020
Q2
$228M Buy
1,635,829
+447,991
+38% +$65.3M 1.44% 10
2020
Q1
$161M Buy
1,187,838
+128,001
+12% +$18.2M 1.23% 18
2019
Q4
$155M Sell
1,059,837
-424,958
-29% -$57.6M 0.95% 22
2019
Q3
$192M Sell
1,484,795
-297,221
-17% -$39.2M 1.19% 17
2019
Q2
$251M Sell
1,782,016
-146,203
-8% -$20.2M 1.26% 10
2019
Q1
$261M Buy
1,928,219
+751,800
+64% +$101M 1.56% 7
2018
Q4
$151M Sell
1,176,419
-751,800
-39% -$105M 1% 18
2018
Q3
$261M Buy
1,928,219
+308,979
+19% +$41.1M 1.55% 7
2018
Q2
$199M Buy
1,619,240
+22,740
+1% +$2.84M 1.29% 10
2018
Q1
$205M Sell
1,596,500
-21,183
-1% -$2.86M 1.4% 7
2017
Q4
$218M Sell
1,617,683
-525
-0% -$73.1K 1.69% 5
2017
Q3
$218M Sell
1,618,208
-44,285
-3% -$5.87M 1.7% 5
2017
Q2
$222M Sell
1,662,493
-47,564
-3% -$6.07M 1.76% 5
2017
Q1
$214M Buy
1,710,057
+2,623
+0.2% +$313K 1.96% 4
2016
Q4
$197M Buy
1,707,434
+85,417
+5% +$9.87M 2.09% 4
2016
Q3
$190M Buy
1,622,017
+135,055
+9% +$16.4M 2.11% 4
2016
Q2
$178M Buy
1,486,962
+76,788
+5% +$8.73M 2.02% 2
2016
Q1
$153M Sell
1,410,174
-29,303
-2% -$3.03M 1.82% 4
2015
Q4
$150M Buy
1,439,477
+193,481
+16% +$19.5M 1.72% 5
2015
Q3
$117M Buy
1,245,996
+61,308
+5% +$5.93M 1.43% 7
2015
Q2
$116M Sell
1,184,688
-8,775
-0.7% -$879K 1.38% 6
2015
Q1
$121M Sell
1,193,463
-51,820
-4% -$5.27M 1.5% 4
2014
Q4
$131M Buy
1,245,283
+10,563
+0.9% +$1.11M 1.65% 4
2014
Q3
$132M Buy
1,234,720
+151,736
+14% +$15.7M 1.79% 5
2014
Q2
$114M Buy
1,082,984
+84,937
+9% +$8.58M 1.72% 5
2014
Q1
$98M Buy
998,047
+50,453
+5% +$4.68M 1.56% 6
2013
Q4
$87.3M Sell
947,594
-17,151
-2% -$1.58M 1.43% 8
2013
Q3
$83.2M Sell
964,745
-24,235
-2% -$2.17M 1.46% 7
2013
Q2
$85.7M Buy
+988,980
New +$83.9M 1.68% 6

Other funds holding JNJ

DekaBank Deutsche Girozentrale's JNJ Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 4,411,321 shares worth $1.1B. The position accounts for 1.81% of the portfolio, ranked #7.

DekaBank Deutsche Girozentrale first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • DekaBank Deutsche Girozentrale held 4,411,321 shares of Johnson & Johnson worth $1.1B as of Q1 2026.
  • DekaBank Deutsche Girozentrale left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 1.81% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #7 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.